SciTransfer
Organization

SPTS TECHNOLOGIES LIMITED

UK semiconductor equipment manufacturer contributing etch and deposition process tools to European chip fabrication pilot lines.

Large industrial companydigitalUKNo active H2020 projects
H2020 projects
3
As coordinator
0
Total EC funding
€180K
Unique partners
106
What they do

Their core work

SPTS Technologies is a semiconductor equipment manufacturer specializing in etch, deposition, and wafer-level packaging processes used in chip fabrication. Based in Newport, UK, they supply process tools and expertise to semiconductor fabs and research pilot lines across Europe. In H2020 projects, they contribute equipment know-how and process development for advanced semiconductor manufacturing — from GaN power devices to sub-2nm node IC technology. Their role is enabling others to manufacture next-generation chips by providing the physical tools and process recipes required.

Core expertise

What they specialise in

3 projects

All three H2020 projects (PowerBase, InForMed, IT2) involve semiconductor fabrication processes where SPTS contributes equipment and process expertise.

GaN power semiconductor fabricationsecondary
1 project

PowerBase focused specifically on GaN pilot lines and compact power applications, their largest funded project at EUR 113K.

Micro-fabrication for medical devicessecondary
1 project

InForMed was an integrated pilot line for micro-fabricated medical devices, showing cross-application versatility.

Advanced node IC technology (2nm and beyond)emerging
1 project

IT2 project (2020-2023) targets IC technology for the 2nm node, involving lithography, metrology, and heterogeneous integration.

Evolution & trajectory

How they've shifted over time

Early focus
GaN power semiconductors
Recent focus
Sub-2nm IC process technology

Their early H2020 work (2015-2018) centered on compound semiconductors — specifically GaN pilot lines for power electronics and micro-fabrication for medical devices. By 2020, their focus shifted decisively toward advanced silicon IC technology at the 2nm node, with keywords spanning lithography, metrology, DTCO/STCO, and heterogeneous integration. This progression mirrors the broader industry trend from application-specific compound semiconductors toward pushing the limits of mainstream IC scaling.

SPTS is moving toward the frontier of semiconductor miniaturization and heterogeneous integration, making them a relevant partner for any consortium working on next-generation chip manufacturing in Europe.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European17 countries collaborated

SPTS consistently participates as a partner rather than leading consortia, which is typical for an equipment supplier contributing specialized tools and process knowledge to larger initiatives. Their 106 unique partners across 17 countries indicate involvement in very large ECSEL-type consortia — the mega-projects of European semiconductor R&D. This means they are well-networked across the European electronics ecosystem but function as a specialist contributor rather than a project driver.

With 106 consortium partners across 17 countries from just 3 projects, SPTS is embedded in the large-scale ECSEL semiconductor consortia that define European chip R&D. Their network spans the major semiconductor-producing countries of Europe.

Why partner with them

What sets them apart

SPTS occupies a specific niche as a UK-based semiconductor equipment manufacturer — a rare profile in European H2020 consortia where most equipment players are headquartered in continental Europe or Asia. Their ability to contribute process tools across both compound semiconductors (GaN) and advanced silicon nodes makes them versatile for different types of pilot line projects. For consortium builders, they bring the physical manufacturing capability that turns research designs into fabricated wafers.

Notable projects

Highlights from their portfolio

  • PowerBase
    Largest SPTS funding (EUR 113K) and focused on GaN pilot lines for compact power applications — a strategic area for European semiconductor sovereignty.
  • IT2
    Targets the 2nm IC node, placing SPTS at the absolute frontier of semiconductor miniaturization in a major ECSEL initiative.
  • InForMed
    Demonstrates cross-sector versatility — applying semiconductor fabrication expertise to medical device manufacturing.
Cross-sector capabilities
Health — micro-fabricated medical devices (demonstrated in InForMed)Energy — GaN power electronics for compact energy conversionManufacturing — advanced process equipment and pilot line developmentTransport — power semiconductor components for electric vehicles
Analysis note: Profile based on only 3 H2020 projects with modest funding levels (EUR 180K total), suggesting SPTS's participation in these large consortia represents a small fraction of their overall business activity. The company's full capabilities in semiconductor equipment likely extend well beyond what is visible in H2020 data alone. The relatively low funding per project is consistent with an equipment supplier providing in-kind or co-funded contributions rather than receiving major research grants.